entertainment -WSS

entertainment

author：fashion 2025-08-12 08:25:53 - browse：1

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： A new nitrogen execution bill also undermines medical licensing

Wikipedia

WSS

Alabama hospital puts IVF treatments on hold

He's a Nobel laureate. Critics say he was misleading on Covid

STAT readers on older presidents, polypills, Medicare, and more

New company forms to vet health AI models, root out weaknesses

'Cuddling' is just what the doctor ordered for a 200

Slain Parkland victim's father speaks out following reenactment

focus

entertainment

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Antivenom research: Lessons from HIV applied in search for universal antidote

Dobbs anniversary: the lost opportunity of abortion as health care

Calls for Trump's election interference trial to be televised part of long debate

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Community Health Systems hospitals under DOJ investigation

State Dept. review finds Biden bears some blame for Afghanistan failures

Pediatricians' group reaffirms support for gender

23andMe had bad news about my health. I wish a person had delivered it

California Joshua trees severely burned in massive wildfire

leisure time

He's a Nobel laureate. Critics say he was misleading on Covid

Dario to buy mental health app maker Twill in cash and stock deal

In utero gene editing: an explainer

Community Health Systems hospitals under DOJ investigation

Why palliative psychiatry is worth discussing

New documents shed light on MD Anderson Cancer Institute feud

explore

Wikipedia

entertainment

hotspot